End point Fenoldopam, n (%) Dopamine, n (%) p

Slides:

Advertisements

Similar presentations

Enrollment and Outcomes Fan Fan Hou, et al. N Engl J Med 2006;354:

Advertisements

Renal damage occurs in 1 out of 4 hypertensives Adapted from Leoncini et al. J Hypertens. 2008;26:

Patient disposition Dichtl W, et al. Am J Cardiol. 2008;102:743-8 AVR = aortic valve replacement; MDCT = multidetector computed tomographic.

ACUTE RENAL FAILURE 吳志仁醫師馬偕醫院腎臟內科. Definition An increase Cr. ≧ 0.5 mg/dl per day An increase of more than 50 % over baseline Cr. A reduction in calculated.

Implementation of RRT improved the survival rate significantly, when blood urea nitrogen or serum creatinine was still low level. However, most of those.

Trial profile Mann JF et al. Lancet 2008;372:

Clinical Outcomes with Newer Antihyperglycemic Agents

Clinical Outcomes with Newer Antihyperglycemic Agents

Angiotensin converting enzyme inhibitors / angiotensin receptor blockers and contrast induced nephropathy in patients receiving cardiac catheterization:

Volume 62, Issue 6, Pages (December 2002)

RIFLE criteria for acute kidney injury

Optimization of pre-ESRD care: The key to improved dialysis outcomes

Enterprise | Interest Nothing to disclose.

CORAL Trial design: Patients with renal artery stenosis and hypertension or chronic kidney disease were randomized to renal artery stenting (n = 467) vs.

Treatment of acute renal failure

Section 3: CKD, CVD and mortality

Primary end point of the ANZICS low-dose dopamine trial

Kwok-lap Chan, MBChB, Patrick Ip, MBBS, Clement S

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:

Introduction: Alarming Statistics Causes of Death in Prevalent Dialysis Patients,

Figure 5 A layered approach to the follow-up of patients with acute kidney disease (AKD) Figure 5 | A layered approach to the follow-up of patients with.

Figure 4 Interplay between acute kidney injury (AKI),

Figure 6 Approach to drug management in patients with acute kidney disease (AKD) Figure 6 | Approach to drug management in patients with acute kidney disease.

LEVO-CTS Trial design: Patients undergoing cardiac surgery with the use of cardiopulmonary bypass were randomized to infusion of levosimendan 0.2 µg/kg/min.

Change in mean LVMI with erythropoietin alpha hemoglobin maintenance treatment and control/delayed treatment from baseline to 24 months End point Hemoglobin.

Volume 89, Issue 6, Pages (June 2016)

Change in mean serum creatinine, PAC-guided vs empiric therapy

Impact of Cognitive Function Change on Mortality in Renal Transplant and End-Stage Renal Disease Patients Sharma et al. Am J Nephrol 2016;44: (DOI: / )

Mean eGFR among survivors after CABG surgery vs all-cause deaths

Figure 2 Milestones in paediatric acute kidney injury (AKI) research

Pharmacodynamic Effects of Sucroferric Oxyhydroxide and Sevelamer Carbonate on Vitamin D Receptor Agonist Bioactivity in Dialysis Patients Sprague et al.

Becker RC, et al. Lancet 2009;373:919-28

Volume 60, Issue 2, Pages (August 2001)

CHAPTER 1 All Renal Replacement Therapy In Malaysia

Risk of perioperative renal dysfunction with N-acetylcysteine or placebo in patients undergoing CABG surgery End point N-acetylcysteine Placebo Relative.

Postoperative renal failure in thoracoabdominal aortic aneurysm repair with simple cross-clamp technique and 4°C renal perfusion Martha M. Wynn, MD,

CREATE: Baseline values

UK Renal Registry 13th Annual Report

TACTICS-HF Trial design: Patients with acute heart failure (reduced or preserved ejection fraction) were randomized to tolvaptan 30 mg at 0, 24, and 48.

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Differing renal outcomes associated with AKI electronic alerts for clinical location of AKI subsets. Differing renal outcomes associated with AKI electronic.

Intravenous Diltiazem and Acute Renal Failure After Cardiac Operations

Composite of complications including cardiovascular (CV): acute myocardial infarction, cardiac arrhythmia requiring medical treatment and heart failure;

POPE-2 Trial design: Patients with moderate to large pericardial effusion after cardiac surgery were randomized to colchicine 2 mg loading dose, then 1.

Volume 76, Issue 8, Pages (October 2009)

Volume 62, Issue 6, Pages (December 2002)

Treatment of acute renal failure

Payan Schober et al. Am J Nephrol 2017;45: (DOI: / )

Volume 76, Issue 10, Pages (November 2009)

Volume 66, Issue 2, Pages (August 2004)

Kai Singbartl, John A. Kellum Kidney International

Entry, Randomization, and Follow-up of Patients in the Hypertension in the Very Elderly Trial Of the 461 patients who did not meet the protocol criteria,

Volume 74, Issue 5, Pages (September 2008)

Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita Kidney International

Volume 60, Issue 3, Pages (September 2001)

Does equal care give equal outcomes?

Kwok-lap Chan, MBChB, Patrick Ip, MBBS, Clement S

American Journal of Kidney Diseases

Low/moderate intensity statins High intensity statins

Optimization of pre-ESRD care: The key to improved dialysis outcomes

Attitude towards deterioration of renal function in terms of baseline serum creatinine level increase in the context of ACE-I therapy. Attitude towards.

Mean changes (standard error) from baseline in A1C (A and B) and body weight (C and D) for patients with type 1 (A and C) or type 2 (B and D) diabetes.

A. Lauschke, U.K.M. Teichgräber, U. Frei, K.-U. Eckardt

Relationship between organ failure and mortality in acute-on-chronic liver failure (ACLF). Relationship between organ failure and mortality in acute-on-chronic.

Effect of methylprednisolone versus placebo on the risk of acute kidney injury in a subsample of patients with serial postoperative serum creatinine assessments.

Dr Donal O’Donoghue National Clinical Director for Kidney Care

Low/moderate intensity statins High intensity statins

Fistula and Survival Outcomes after Fistula Creation among Predialysis Chronic Kidney Disease Stage 5 Patients Miyamoto et al. Am J Nephrol 2017;45:

Diagnostic criteria for AKI

Avasare et al. Am J Nephrol 2017;45:99-106 (DOI: / )

Presentation transcript:

Outcomes post cardiac surgery in patients treated with fenoldopam vs dopamine End point Fenoldopam, n (%) Dopamine, n (%) p Acute renal failure (25% increase in serum creatinine from baseline) 17 (42.5) 16 (40) 0.9 Renal replacement therapy 4 (10) Death 3 (7.5) 0.5 Bove T et al Circulation 2005; 111:3230-3235.

Outcomes with fenoldopam vs placebo in patients with acute tubular necrosis End point Fenoldopam, n (%) Placebo, n (%) p Dialysis therapy and/or death at 21 days 22 (27.5) 29 (38.7) 0.235 Dialysis therapy 13 (16.25) 19 (25.3) 0.163 Death at 21 days (%) 13.8 25.3 0.068 Tumlin JA et al. Am J Kidney Dis 2005; 46:26-34. .